Filtered By:
Management: WHO
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 29554 results found since Jan 2013.
Using Aromatherapy to Improve Nighttime Comfort in Hospitalized Patients With Cancer: A Pilot Study
Clin J Oncol Nurs. 2023 Jul 20;27(4):389-396. doi: 10.1188/23.CJON.389-396.ABSTRACTBACKGROUND: Sleep disturbances have been shown to have negative health effects leading to inferior well-being, increased fatigue, and impaired performance. For hospitalized patients receiving oncology care, improving nighttime comfort may positively affect well-being and health outcomes, leading to decreased length of stay. Aromatherapy can improve sleep quantity and quality.OBJECTIVES: This pilot study aimed to determine whether aromatherapy improves nighttime comfort, in particular well-being and sleep quality, for hospitalized patients wi...
Source: Clinical Journal of Oncology Nursing - September 7, 2023 Category: Nursing Authors: Leah Ann Phillips Marwa Kilani Sherri Mendelson Ross J Bindler Source Type: research
Patient Safety Error Reporting Education for Undergraduate Nursing Students: A Scoping Review
CONCLUSION: For more effective error reporting education, active teaching methods such as virtual reality simulations and planning, applying, and evaluating methods for long-term direct clinical error reporting are required. [J Nurs Educ. 2023;62(9):489-494.].PMID:37672496 | DOI:10.3928/01484834-20230712-04
Source: The Journal of Nursing Education - September 6, 2023 Category: Nursing Authors: Mi Ok Song So Young Yun Aeri Jang Source Type: research
Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain
CONCLUSION: Due to the rising costs associated with newly available therapies, structured, reproducible, and field-tested tools to evaluate the added clinical benefit from these therapies need to be implemented in pre-selecting potential candidate medicines to be included in the WHO EML. ESMO is proud to collaborate closely with WHO on this important global public health initiative.PMID:37672862 | DOI:10.1016/j.esmoop.2023.101617
Source: Cancer Control - September 6, 2023 Category: Cancer & Oncology Authors: F Roitberg T Amaral N I Cherny R Giuliani N J Latino M Galotti G Bricalli G Curigliano G Pentheroudakis D Trapani Source Type: research
A history of thalidomide in India
This article challenges this view by showing that the drug entered the Indian subcontinent through the former Portuguese territory of Goa around 1960. We examine the subsequent development of its distribution, use and regulation in India from the mid-1960s up to the present situation. Colonial legacies are a crucial explanation for the early appearance of thalidomide on the Indian subcontinent. They also influenced its re-emergence as drug for treating leprosy reactions in India after 1965. We identify key actors in this process: the original German producer that delivered thalidomide free of charge, European doctors who w...
Source: Medical History - September 5, 2023 Category: History of Medicine Authors: Ludger Wimmelb ücker Anita Kar Source Type: research
Andrija Štampar as president of the interim commission of the world health organization
Acta Med Hist Adriat. 2023 Jul 18;21(1):141-156.ABSTRACThttps://doi.org/10.31952/amha.21.1.6 This paper provides an analysis of Andrija Štampar's activities after World War II on the establishment of effective international health. Analyzed archival materials have confir- med with numerous evidence that Štampar as the president of the Interim Commission of the World Health Organization (WHO) played a crucial role in the establishment of the ideological starting points and organization of the WHO system, which remain relevant to date. Apart from the strategic foundations, it has been shown that his principles regarding th...
Source: Medical History - September 5, 2023 Category: History of Medicine Authors: Alen Ru žić Željko Dugac Source Type: research
